New database aims to unravel mysteries of chronic cough
NCT ID NCT04882943
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to create a French database of adults with chronic cough (lasting over 8 weeks) to learn more about the condition and how many people have a cough that doesn't get better with treatment. Researchers planned to collect information from 178 patients across multiple hospitals. The study was terminated early, but its goal was to gather knowledge, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
178 people
The number who actually took part.
- Started
-
Jun 2021
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
chronic cough patients
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years old * Consultation motivated by cough lasting for more than 8 weeks (duration corresponding to the definition of chronic cough) * Patient covered by a National Health Insurance Exclusion Criteria: * Active smoker or recent smoking cessation (within the past 6 months) * Intake of medications causing cough (the patient can be included 4 weeks after treatment discontinuation if cough persists) * Pregnant or breast-feeding women * Upper or lower respiratory tract infection within the past 4 weeks * Active lung disease (such as interstitial lung disease, lung cancer, abnormal dilation of the bronchi). * History of chronic bronchitis. * Current treatment with an angiotensin converting enzyme (ACE) inhibitor * History of cancer within the past 5 years or active cancer (excluding cutaneous squamous-cell carcinoma). * Person not fluent in French * Adult not able to express his/her consent verbally * Patient refusal
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Refractory chronic cough are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Bichat
Paris, France
-
CH de Libourne
Libourne, France
-
CHU de Besançon
Besançon, France
-
CHU de Bordeaux
Bordeaux, France
-
CHU de Tours
Tours, France
-
UHToulouse
Toulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill aims to silence chronic cough that Won't quit
- New pill aims to silence stubborn chronic cough
- New hope for chronic coughers: experimental drug enters final testing phase
- Can cough training and a natural inhaler silence chronic cough?
- New cough pill shows promise in clinical trial
- New pill aims to silence stubborn coughs